Large scale use of SARS-CoV-2 antigen-based detection tests: a three-month experience in Guatemala, June-August 2020
Rev Panam Salud Pública
; 44, dic. 2020https://doi.org/10.26633/RPSP.2020.174.
Article
in En
| PAHOIRIS
| ID: phr-53144
Responsible library:
US1.1
ABSTRACT
[ABSTRACT]. Objectives. To measure protocol adherence and antigen-based detection tests (AgDT) negative predictive value after 3 months of massive use as a diagnostic tool for COVID-19 in Guatemala. Methods. The study period included nasopharyngeal swabs taken between March 12 and August 31, 2020, which results were entered in the national COVID-19 information system. Proportional increase in testing between one month before and one month after the introduction of AgDT (May 9–June 8 vs. June 9–July 8) was measured. Results. After AgDT introduction, there was a 139% increase in SARS-CoV-2 testing. Between June 9 and August 31, 7.8% of 110 657 AgDT-negative patients had follow-up RT-PCR testing. Of them, 30% were RT-PCR positive. Conclusions. While introducing AgDT improved access to diagnostics, ensuring the availability of timely RT-PCR capacities to confirm diagnosis is also key.
Full text:
1
Collection:
04-international_org
Database:
PAHOIRIS
Main subject:
Coronavirus Infections
/
Clinical Laboratory Techniques
/
Reverse Transcriptase Polymerase Chain Reaction
/
Laboratory Test
/
COVID-19
/
Guatemala
Type of study:
Diagnostic_studies
/
Guideline
Country/Region as subject:
America central
/
Guatemala
Language:
En
Year:
2020
Document type:
Article